Overview
Chonluten is a specialized short-chain peptide bioregulator designed to target the respiratory system. Developed by Russian researchers for elite military and athletic applications, it functions at a genetic level to enhance the repair and maintenance of bronchial tissues. Unlike stimulant-based respiratory aids, Chonluten works by reprogramming cellular behavior, encouraging the synthesis of essential proteins and stabilizing the extracellular matrix within the lungs.
Beyond simple tissue repair, the peptide provides a robust defense against oxidative stress and chronic inflammation. By balancing the immune response within the respiratory tract, it helps individuals recover from persistent viral infections and long-term pulmonary issues. For athletes and biohackers, it serves as a tool to improve breathing efficiency and endurance, ensuring that respiratory capacity does not become a bottleneck during intense physical exertion.
Mechanism of action
Chonluten is a synthetic tripeptide (EDP) bioregulator that interacts with DNA to modulate gene expression specifically within bronchial epithelial cells, promoting cellular regeneration and reducing pro-inflammatory cytokine activity.
Reported benefits
- ▸Accelerates healing following respiratory infections and bronchitis.
- ▸Enhances oxygen utilization and stamina during high-intensity training.
- ▸Modulates inflammatory markers like IL-6 and TNF to protect lung tissue.
- ▸Stimulates the production of structural proteins for bronchial repair.
- ▸Assists in managing chronic conditions such as asthma or COPD.
Reported side effects
- ·Generally well-tolerated with no major reported adverse effects in literature.
Often stacked with
ThymalinBPC-157Crystallin